Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Trdmt1em1/Cya
Common Name:
Trdmt1-KO
Product ID:
S-KO-01787
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Trdmt1-KO
Strain ID
KOCMP-13434-Trdmt1-B6N-VA
Gene Name
Trdmt1
Product ID
S-KO-01787
Gene Alias
Dnmt2; Rnmt2; m.MmuIIP; met-2
Background
C57BL/6NCya
NCBI ID
13434
Modification
Conventional knockout
Chromosome
2
Phenotype
MGI:1274787
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Trdmt1em1/Cya mice (Catalog S-KO-01787) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000124488
NCBI RefSeq
NM_010067
Target Region
Exon 3~5
Size of Effective Region
~2.9 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Trdmt1, also known as DNMT2, is a 5-methylcytosine methyltransferase initially misclassified as a DNA methyltransferase. It can methylate both tRNA and mRNA, promoting tRNA stability, proper protein synthesis, and orchestrating DNA damage response (DDR) and DNA stability. It is involved in various physiological regulatory processes such as gene expression, immune response, and is associated with multiple diseases including cancer [1,2].

Gene knockout (KO) studies have provided significant insights. In cancer cells, Trdmt1 KO can sensitize them to radiotherapy and chemotherapy [1]. In a study on doxorubicin-induced endoplasmic reticulum (ER) stress, Trdmt1 KO compromised the unfolded protein response and sensitized cancer cells to ER stress-induced apoptosis [3]. In glioblastoma cells, Trdmt1 KO led to decreased levels of total 5-methylcytosine in DNA, DNMT1, and DNMT activity, and affected DNA methylome-related processes [5]. In rats, Trdmt1 KO made them more vulnerable to LPS-induced inflammation, indicating its protective role in inflammation through the TLR4-NF-κB/MAPK-TNF-α pathway [4]. In granulosa cells, Trdmt1 mutants with reduced/increased RNA m5C methylation activity severely impaired/enhanced DNA repair following reactive oxygen species induction, suggesting its role in the DNA damage repair related to premature ovarian failure [6]. In ovarian cancer, the G155V mutation in Trdmt1 led to hyper-ubiquitination, reduced Trdmt1 levels, impaired homologous recombination, and sensitized cells to cisplatin [7].

In conclusion, Trdmt1 plays essential roles in multiple biological processes and diseases. KO models have been crucial in revealing its functions, such as in cancer response to therapy, inflammation regulation, DNA damage repair, and homologous recombination. These findings contribute to understanding the mechanisms underlying various diseases and suggest Trdmt1 as a potential therapeutic target [1,3,5,7,8].

References:

1. Lewinska, Anna, Adamczyk-Grochala, Jagoda, Wnuk, Maciej. 2023. TRDMT1-mediated RNA C-5 methylation as a novel target in anticancer therapy. In Biochimica et biophysica acta. Reviews on cancer, 1878, 188964. doi:10.1016/j.bbcan.2023.188964. https://pubmed.ncbi.nlm.nih.gov/37625528/

2. Li, Huari, Liu, Huiru, Zhu, Daiyun, Zhang, Mengjie, Wan, Ziyu. 2024. Biological function molecular pathways and druggability of DNMT2/TRDMT1. In Pharmacological research, 205, 107222. doi:10.1016/j.phrs.2024.107222. https://pubmed.ncbi.nlm.nih.gov/38782147/

3. Adamczyk-Grochala, Jagoda, Bloniarz, Dominika, Zielinska, Klaudia, Lewinska, Anna, Wnuk, Maciej. 2022. DNMT2/TRDMT1 gene knockout compromises doxorubicin-induced unfolded protein response and sensitizes cancer cells to ER stress-induced apoptosis. In Apoptosis : an international journal on programmed cell death, 28, 166-185. doi:10.1007/s10495-022-01779-0. https://pubmed.ncbi.nlm.nih.gov/36273376/

4. Li, Zhengguang, Qi, Xiaolong, Zhang, Xu, Zhang, Lianfeng, Ma, Yuanwu. . TRDMT1 exhibited protective effects against LPS-induced inflammation in rats through TLR4-NF-κB/MAPK-TNF-α pathway. In Animal models and experimental medicine, 5, 172-182. doi:10.1002/ame2.12221. https://pubmed.ncbi.nlm.nih.gov/35474613/

5. Zabek, Tomasz, Szmatola, Tomasz, Adamczyk-Grochala, Jagoda, Lewinska, Anna, Wnuk, Maciej. 2023. Knockout of TRDMT1 methyltransferase affects DNA methylome in glioblastoma cells. In Journal of neuro-oncology, 163, 61-69. doi:10.1007/s11060-023-04304-8. https://pubmed.ncbi.nlm.nih.gov/37169948/

6. Sha, Chunli, Chen, Lu, Lin, Li, Li, Yuefeng, Zhu, Xiaolan. 2021. TRDMT1 participates in the DNA damage repair of granulosa cells in premature ovarian failure. In Aging, 13, 15193-15213. doi:10.18632/aging.203080. https://pubmed.ncbi.nlm.nih.gov/34100772/

7. Zhu, Xiaolan, Wang, Xiangyu, Yan, Wei, Li, Hong-Yu, Lan, Li. 2021. Ubiquitination-mediated degradation of TRDMT1 regulates homologous recombination and therapeutic response. In NAR cancer, 3, zcab010. doi:10.1093/narcan/zcab010. https://pubmed.ncbi.nlm.nih.gov/33778494/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest